Reconstruction Technologies of Complex Oncologic Defects
A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Biomedical Engineering and Biomaterials".
Deadline for manuscript submissions: closed (1 January 2024) | Viewed by 1203
Special Issue Editors
Interests: foreign body reactions; peri-prosthetic disease; tissue-implant interactions; breast cancer reconstruction
Interests: osteoimmunology; bone repair; inorganic polyphosphates; hypoxia; tissue engineering; ligaments; tendons; bone healing; drug release
Interests: 3D printing; biofabrication; drug delivery; musculoskeletal disease; bone/ligament repair; bone metastases; scaffolds
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The capacity to reconstruct the bony and soft tissue defects resulting from oncologic resection remains a critical limiting factor in whether a tumor is deemed resectable. Advances in biomaterial innovation and bioengineering have yielded a breadth of novel treatment strategies for reconstructing oncologic defects, expanding the indications for tumor extirpation. The specific requirements of individual defects—structural, functional, and aesthetic, spanning a wide range of anatomic areas—are all important considerations and broad innovation is required in order to advance reconstructive modalities. Current standard repair strategies all have unwanted drawbacks, necessitating the need to improve repair strategies.
In this Special Issue, we will celebrate novel and cutting-edge strategies developed for use in improved oncologic defect repair. An example of such a method would be the use of biomaterial innovations to recreate rigid structural tissues in the case of bony defects or deformable materials in order to reconstruct soft tissue defects, cell-based therapies, and printed scaffolds which restore tissue integrity with viable materials, and the deploymenty of many more different emerging techniques to reconstruct complex oncologic defects. We welcome full-length original research studies, letters, clinical cases, and reviews outlining advances in oncologic reconstruction technology.
Dr. Joshua Vorstenbosch
Dr. Rahul Gawri
Dr. Derek H. H. Rosenzweig
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oncologic reconstruction
- biomaterials
- tissue scaffolds
- cell-based therapies
- tissue engineering
- surgical oncology
- medical devices
- 3D printing
- drug delivery
